About The Event
Learning category:
N/A
Learning objectives:
- Participants will distinguish World Health Organization
(WHO) international classifications of disease (ICD-10) vs.
American Psychiatric Association (APA) classifications for
substance use disorders (DSM-5); - Participants will identify the commonly used substances
in Nigeria; - Participants will state the associated impacts of substance
use and dependence in Nigeria; - Participants will discuss risk factors and mechanisms for
substance use disorders; - Participants will explain the current prevention &
treatment practices in Nigeria; and - Participants will describe best practices for substance
dependence treatment
Abstract:
Addictions nursing practice and care has a rich history since the
advent of formal services for the treatment of substance use
disorders, yet there is still no universally agreed role definition,
standard scope of practice, or certification process in the UK. Despite
multiple accounts of how nurses innovated, broke down barriers,
and advanced the treatment and recovery agenda, the value of the
addictions nurse specialist role has in recent times been threaten, as
NHS addiction services are decommissioned, or transferred into nontraditional non-statutory sectors. This presentation will discuss the
challenges currently facing addictions nurses as they seek to identify,
protect, and advocate for their place within the pull and push of policy
and structural changes. The authors will present highlights from a
qualitative survey of ‘expert addiction nurses’ on factors which may
have accounted for how addiction nursing is currently perceived, and
invite participants to engage in a wider piece of work that is currently
exploring the experience of nurses in relation to their preparation
and engagement in working with problematic substance use in their
respective countries.
Author(s):
Oluremi Adejumo, DNP, MSc., RN
Assistant Professor, University of Maryland, School of Nursing; and
Assistant Professor, Johns Hopkins School of Nursing, Baltimore
Dr. Oluremi Adejumo’s primary goal is to help strengthen the nursing
capacity in the U.S. and abroad – making prevention a priority, most
specifically in Nigeria and other African nations. As a translational
leader she has facilitated many community-based programs’
development, even in a complex adaptive system. Her expertise lies
in translation of evidence-based research to practice. To share her
expertise, she mentors other nurses to be more effective and efficient
in their practice delivery, as they perform patient-centered care.
As a proactive leader, her aim to empower other nurses is evidenced
in her engagements in nursing activities that foster professional
growth. When Dr. Adejumo recognized the threat being posed by
substance misuse to the citizens of Nigeria, within a short duration of
her membership and engagements with the International Nurses
Society on Addictions (IntNSA), she facilitated the establishment of
the first chapter in Africa – IntNSA-Nigeria, as she works collaboratively
with her nursing colleagues and healthcare professionals from other
disciplines.
Katherine Fornili, DNP, MPH, RN, CARN, FIAAN
Professor of Health Policy at Middlesex University where she is a codirector of the Drugs and Alcohol Research Centre
Katherine Fornili has been on the full-time faculty at the University of
Maryland School of Nursing since 2005. She holds a baccalaureate
degree in nursing, a masters’ degree in public health, and a Doctor
of Nursing Practice (DNP) degree in community/public health
nursing with an emphasis on addictions nursing. Dr. Fornili currently
teaches in the DNP program, as well as an undergraduate clinical in
community/public health nursing and is a co-developer of several
addictions nursing and motivational interviewing courses. A public
health nurse for 36 years, Dr. Fornili has served in leadership roles at
the city, state and national levels since 1993, and has been certified
in addictions registered nursing (CARN) since 1999. She has served
in doctoral internships at SAMHSA and the White House Office
of National Drug Control Policy (ONDCP). She has extensive state
agency experience leading grant-writing teams for communitybased substance use disorder prevention and treatment programs.
Dr. Fornili is an Associate Editor of the Journal of Addictions Nursing,
and editor of the Policy Watch column. She co-authored SAMHSA’s
Technical Assistance Publication (TAP) Number 30: Buprenorphine:
A Guide for Nurses and was a Field Reviewer for Treatment
Improvement Protocol (TIP) Number 63: Medications for Opioid Use
Disorder. She has served four previous terms on the IntNSA Board of
Directors and as Chair of the IntNSA Health Policy Task Force and is the
President of IntNSA for 2018-2020. Her interests include addictions
nursing curriculum development, substance screening and brief
intervention, pharmacological therapies (specifically buprenorphine),
stigma, health policy, public health and health disparities.
